MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety

Eli O. Meltzer* (Corresponding Author), Craig LaForce, Paul Ratner, David Price, David Ginsberg, Warner Carr

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

73 Citations (Scopus)

Fingerprint Dive into the research topics of 'MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety'. Together they form a unique fingerprint.

Medicine & Life Sciences